Innovation Pharmaceuticals Inc (IPIX)

[biodoc]

Great work DaubersUP!

Nice to see it in writing and consistent with what Leo has expressed or suggested. For B-OM alone, an oncology-focused midsize pharma might allow for the most generous upfront payment and a more efficient vehicle to marketing approval than a BP. Perhaps a company like Eisai. I'm sure there are a bunch of others that would be a good fit with the resources to efficiently move B-OM forward.

“BD Agreement” means a significant licensing arrangement with a pharmaceutical company that will include an initial (“up-front”) payment to the Company in an amount in the double-digits millions of dollars and will arrange for such pharmaceutical company to undertake the continuing development of the Company’s Brilacidin compound in the indication of Oral Mucositis, including the conducting and funding of clinical trials aiming towards the filing of an NDA.
https://www.bamsec.com/filing/147793218003269/4?cik=1355250

biodoc